Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models.

Journal: Journal of chemical information and modeling
Published Date:

Abstract

Machine learning provides effective computational tools for exploring the chemical space via deep generative models. Here, we propose a new reinforcement learning scheme to fine-tune graph-based deep generative models for molecular design tasks. We show how our computational framework can successfully guide a pretrained generative model toward the generation of molecules with a specific property profile, even when such molecules are not present in the training set and unlikely to be generated by the pretrained model. We explored the following tasks: generating molecules of decreasing/increasing size, increasing drug-likeness, and increasing bioactivity. Using the proposed approach, we achieve a model which generates diverse compounds with predicted DRD2 activity for 95% of sampled molecules, outperforming previously reported methods on this metric.

Authors

  • Sara Romeo Atance
    Molecular AI, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, 431 50Mölndal, Sweden.
  • Juan Viguera Diez
    Molecular AI, Discovery Sciences, R&D, AstraZeneca Gothenburg, Pepparedsleden 1, 431 50Mölndal, Sweden.
  • Ola Engkvist
    Hit Discovery, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, 431 83, Mölndal, Sweden.
  • Simon Olsson
    Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Rocío Mercado
    Discovery Sciences, R&D, AstraZeneca, Gothenburg 43183, Sweden.